About 66 results
Open links in new tab
  1. Syntegon – strategic lifecycle partner to the pharma, biotech, and food ...

    We are the strategic lifecycle partner to the pharma, biotech, and food industries. We support our customers with seamless processes, innovative technologies, and sustainable solutions.

  2. Company profile » Syntegon

    Syntegon is a global leader in technology solutions for the pharmaceutical, biotech, and food industries, enhancing efficiency, sustainability, and product quality.

  3. Locations » Syntegon

    The Syntegon Group with more than 30 locations and several subsidiaries in nearly 20 countries is represented in all regions of the world.

  4. Syntegon – strategischer Lifecycle-Partner der Pharma-, Biotech- und ...

    Strategischer Partner der Pharma-, Biotech- und Lebensmittelindustrie. Wir bieten reibungslose Prozesse, innovative Technologien und nachhaltige Lösungen.

  5. Contact Us - Syntegon

    Our consolidated network of Syntegon locations and long-term sales and service partners guarantees that we are on the spot to support you quickly.

  6. Pharma solutions » Syntegon

    As a leading provider of pharma solutions, we enhance the time to market of drug developments and ensure the quality of medicines.

  7. Services - Syntegon

    With a comprehensive service portfolio, our global network of experts supports our customers throughout the entire lifecycle of their lines.

  8. Jobs and career at Syntegon

    We are Syntegon Together with 7.300 colleagues worldwide, we are the strategic lifecycle partner for the pharmaceutical, biotech, and food industries. With seamless processes, innovative technologies, …

  9. Syntegon delivers strong growth and EBITDA improvements in the first ...

    Sep 2, 2025 · Syntegon reports robust growth in H1 2025, driven by strong Pharma segment performance, achieving increased sales, improved EBITDA margins, and successful innovation …

  10. Syntegon delivers record results in 2024

    May 15, 2025 · The Syntegon Group, a leading strategic partner to the global pharmaceutical, biotech and food industries, reported record results for fiscal year 2024.